Cheil Bio Co

Cheil Bio Co EV/EBITDA

Delisted·Feb 25, 2026

The EV/EBITDA (Enterprise Value to EBITDA) of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is -6.45. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 7.08 — a change of -191.04% (lower).

EV/EBITDA

-6.45

YoY

-191.04%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Cheil Bio Co is 2024 -6.45 . EV/EBITDA (Enterprise Value to EBITDA) of Cheil Bio Co was 2023 7.08 . It decreases by -191.04% lower compared to the previous year.

The Cheil Bio Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2017
-5.19 KRW
Jan 1, 2018
-4.81 KRW
Jan 1, 2019
-17.61 KRW
Jan 1, 2020
54.05 KRW
Jan 1, 2021
12.17 KRW
Jan 1, 2022
10.81 KRW
Jan 1, 2023
7.08 KRW
Jan 1, 2024
-6.45 KRW
The Cheil Bio Co EV/EBITDA history
YEAREV/EBITDAYoY
-6.45-191.04%
7.08-34.48%
10.81-11.17%
12.17-77.48%
54.05-406.84%
-17.61+266.27%
-4.81-7.34%
-5.19-61.11%
-13.34+62.45%
-8.21-225.20%
6.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

EV/EBITDA (Enterprise Value to EBITDA) of Cheil Bio Co is -6.45 in 2024.

EV/EBITDA (Enterprise Value to EBITDA) of Cheil Bio Co changed from 7.08 to -6.45, representing a -191.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Cheil Bio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cheil Bio Co

All Key Metrics — Cheil Bio Co